Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 1;28(12):1358-1360.e2.
doi: 10.1016/j.str.2020.07.014. Epub 2020 Aug 11.

DStabilize: A Web Resource to Generate Mirror Images of Biomolecules

Affiliations
Free article

DStabilize: A Web Resource to Generate Mirror Images of Biomolecules

Ashar J Malik et al. Structure. .
Free article

Erratum in

Abstract

Peptides comprising D-amino acids have been shown to be resistant to proteolysis. This makes them potential candidates as probes of cellular interactions, notably protein-biomolecule interactions. However, the empirical conversion of the amino acids that constitute a peptide from L-forms to D-forms will result in abrogation of the normal interactions made by the L-amino acids due to side-chain orientation changes that are associated with the changes in chirality. These interactions can be preserved by reversing the sequence of the D-peptide. We present a web server (http://dstabilize.bii.a-star.edu.sg/) that allows users to convert between L-proteins and D-proteins and for sequence reversal of D-peptides, along with the capability of performing other empirical geometric transforms. This resource allows the user to generate structures of interest easily for subsequent in silico processing.

Keywords: D-proteins; enantiomers; peptide design; protein structure transformation; retero-inverso.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests C.S.V. is founder director of SiNOPSEE Therapeutics and Aplomex. C.S.V. and P.G.A.A. are part of a team in A(∗)STAR who have a joint patent application with MSD International (P53 activator peptidomimetic macrocycles. US patent application no. 62864531, filed June 2019. Patent pending); C.S.V. receives research funding for his group (in the Bioinformatics Institute, A(∗)STAR) from MSD International for work on peptides; A.J.M. and P.G.A.A. declare no competing interests.

Publication types

LinkOut - more resources